Overview

Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
We evaluate the efficacy and tolerability of duloxetine in the treatment of major depressive episodes during the course of psychotic disorders
Phase:
Phase 4
Details
Lead Sponsor:
Central Institute of Mental Health, Mannheim
Treatments:
Duloxetine Hydrochloride